Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126372662 | 12637266 | 2 | F | 2016 | 20160811 | 20160809 | 20160826 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002386 | VALIDUS | 0.00 | Y | 0.00000 | 20160826 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126372662 | 12637266 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | UNK | U | 17963 | |||||||||
| 126372662 | 12637266 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (ONCE A MONTH) | U | 0 | 20 | MG | |||||||
| 126372662 | 12637266 | 3 | C | AVAPRO | IRBESARTAN | 1 | UNK | U | 0 | ||||||||||
| 126372662 | 12637266 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 126372662 | 12637266 | 5 | C | VITAMINS NOS | VITAMINS | 1 | UNK | U | 0 | ||||||||||
| 126372662 | 12637266 | 6 | C | VITAMIN B 1-6-12 | CYANOCOBALAMINPYRIDOXINETHIAMINE | 1 | UNK | U | 0 | ||||||||||
| 126372662 | 12637266 | 7 | C | MAGNESIUM | MAGNESIUM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126372662 | 12637266 | 1 | Product used for unknown indication |
| 126372662 | 12637266 | 2 | Carcinoid syndrome |
| 126372662 | 12637266 | 3 | Product used for unknown indication |
| 126372662 | 12637266 | 4 | Product used for unknown indication |
| 126372662 | 12637266 | 5 | Product used for unknown indication |
| 126372662 | 12637266 | 6 | Product used for unknown indication |
| 126372662 | 12637266 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126372662 | 12637266 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126372662 | 12637266 | Abdominal pain upper | |
| 126372662 | 12637266 | Decreased appetite | |
| 126372662 | 12637266 | Hepatic lesion | |
| 126372662 | 12637266 | Malignant neoplasm progression | |
| 126372662 | 12637266 | Metastases to liver | |
| 126372662 | 12637266 | Pain in extremity | |
| 126372662 | 12637266 | Peripheral swelling | |
| 126372662 | 12637266 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126372662 | 12637266 | 2 | 20110228 | 0 | ||
| 126372662 | 12637266 | 7 | 20160805 | 0 |